Gregory Stein

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Part of OPKO Health, Inc., Waratah Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in Calgary, Canada. The Canadian company was founded by Susan Dana Jones. Waratah Pharmaceuticals was acquired by Transition Therapeutics, Inc., part of OPKO Health, Inc. from September 01, 2016 on January 28, 2002 for $15.46 million.

Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC.

NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada.

Peplin, Inc. develops drugs and pharmaceutical products. The company was founded by James Harrison Aylward in 1998 and is headquartered in Emeryville, CA.

Part of Baxter International, Inc., Clintec International, Inc. is a pharmaceutical company based in Deerfield, IL. The company specializes in the development and distribution of pharmaceutical products.

Hunter Immunology Ltd. operates as a biotechnology company. It develops immune modulators for treatment of respiratory diseases. The company was founded by Phillip Comans in 2003 and is headquartered in Victoria, Australia.

Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA.

Breathe Easy Ltd. develops drug for cystic fibrosis. It is developing an inhaled medicine called Citramel, as a core therapy to improve lung function and to potentially enhance the effectiveness of other inhaled CF therapies such as antibiotics. The company was founded on April 30, 2009 by Brent Stuart Ogilvie, Robert bartlett Elliott and Andrea Miller and is headquartered in Auckland, New Zealand.

Pacific Channel Ltd (Pacific Channel) is a venture capital firm founded in 2006 by Brent S. Ogilvie. The firm is headquartered in Auckland, New Zealand.

Prismic Pharmaceuticals, Inc. engages in the research and development of prescription drugs for kidney disease, mental health, and chronic pain. It also offers medical foods for patients with chronic kidney disease, and depression and bipolar disorder. The company was founded by Zachary Dutton, Danilo Casadei Massari, and Peter J. Moriarty in 2011 and is headquartered in Worcester, MA.

Footfalls & Heartbeats (UK) Ltd. designs, develops, and manufactures smart textiles. The firm uses nano-scale interactions within the textile to make the fabric itself the sensor, avoiding the need for wires or miniature electronics. The company was founded by Simon McMaster in 2010 and is headquartered in Nottingham, the United Kingdom.

Engender Technologies Ltd. engages in the research and development of gender selection especially in the dairy industry. The company was founded by Miriam Cather Simpson on October 6, 2011 and is headquartered in Auckland, New Zealand.

Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand.

View Point Medical, Inc. engages in the provision of medical device and technology focuses on surgical outcomes using novel tissue markers that enable lesion localization in cancer care. It offers SignalMark platform. The company was founded by William Blair and Jeffrey Port and is headquartered in Carlsbad, CA.

Immunicom, Inc. engages in the development, clinical and regulatory affairs, manufacturing, and global commercialization of medical devices and pharmacologic therapies. It specializes in the treatment approach of cancer, inflammatory diseases, and autoimmune diseases. The company was founded by Amir Jafri and is headquartered in San Diego, CA.

LoveMyDelta, Inc. provides technology services. The company is headquartered in Philadelphia, PA.

Praesidia Biotherapeutics, Inc. is a company that specializes in developing drugs using their proprietary Tunable Linker Technology called LESS (Linker Enzyme Substrate System). The company is based in Arlington, MA. This technology helps to maximize the therapeutic potential of drugs. The company was founded by Sohang Chatterjee, Pradip K. Majumder, and Santosh Kesari, with Sohang Chatterjee serving as the CEO since incorporation.

Avacen, Inc. provides non-invasive medical device that provides temporary relief for arthritis, muscle and joint pain. The company was founded by Thomas G. Muehlbauer and Danielle J Forsgren in 2008 and is headquartered in San Diego, CA.